Sneha Gopalan

Sneha Gopalan

Auto-generated profile, based on publicly available information

Sneha Gopalan

Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2021 in Molecular Cell
Verified
Journal Article
Closed access
SGSneha Gopalan
Sneha Gopalan
YWYuqing Wang
Yuqing Wang
NHNicholas W. Harper
Nicholas W. Harper
MGManuel Garber
Manuel Garber
TFThomas G. Fazzio
Thomas G. Fazzio

23 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLoretah Chibaya
Loretah Chibaya
KMKatherine C. Murphy
Katherine C. Murphy
YLYvette Lopez-Diaz
Yvette Lopez-Diaz
KDKelly D. DeMarco
Kelly D. DeMarco
HLHaibo Liu
Haibo Liu
MRMarcus Ruscetti
Marcus Ruscetti
T cell-activating immunotherapies that produce durable and even curative responses in some malignancies have failed in pancreatic ductal adenocarcinoma (PDAC) due to rampant immune suppression and poor tumor immunogenicity. We and others have demonstrated that induction of cellular senescence and its accompanying senescence-associated secretory phenotype (SASP) can be an effective approach to activate not only T cell but also cytotoxic Natural Killer (NK) cell-mediated anti-tumor immunity. Here we found that the pancreas tumor microenvironment (TME) suppresses NK and T cell surveillance following therapy-induced senescence through EZH2-mediated repression of pro-inflammatory SASP genes. Genetic or pharmacological inhibition of EZH2 or its methyltransferase activity stimulated the production of pro-inflammatory SASP chemokines CCL2 and CXCL9/10 that led to enhanced NK and T cell infiltration and tumor eradication in preclinical PDAC mouse models. EZH2 activity was also associated with suppression of SASP-associated inflammatory chemokines and cytotoxic lymphocyte immunity and reduced overall survival in a PDAC patient cohort. These results demonstrate that EZH2 mediates epigenetic repression of the pro-inflammatory SASP in the pancreas TME, and that EZH2 blockade in combination with senescence-inducing therapies could be a powerful means to potentiate NK and T cell surveillance in PDAC to achieve immune-mediated tumor control.

30 March 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAdwait A. Godbole
Adwait A. Godbole
SGSneha Gopalan
Sneha Gopalan
TNThien-Kim Nguyen
Thien-Kim Nguyen
AMAlexander Munden
Alexander Munden
PVPaula Vo
Paula Vo
AWAmy K. Walker
Amy K. Walker
Methylation is a widely occurring modification that requires the methyl donor S-adenosylmethionine (SAM) and acts in regulation of gene expression and other processes. SAM is synthesized from methionine, which is imported or generated through the 1-carbon cycle (1CC). Alterations in 1CC function have clear effects on lifespan and stress responses, but the wide distribution of this modification has made identification of specific mechanistic links difficult. Exploiting a dynamic stress-induced transcription model, we find that two SAM synthases in Caenorhabditis elegans , SAMS-1 and SAMS-4, contribute differently to modification of H3K4me3, gene expression and survival. We find that sams-4 enhances H3K4me3 in heat shocked animals lacking sams-1 , however, sams-1 cannot compensate for sams-4 , which is required to survive heat stress. This suggests that the regulatory functions of SAM depend on its enzymatic source and that provisioning of SAM may be an important regulatory step linking 1CC function to phenotypes in aging and stress.